
New CEO at LINK Medical 24 January 2025
Oslo Norway, January 24, 2025. The LINK Medical Board is pleased to announce the appointment of Anders... Read more
Oslo Norway, January 24, 2025. The LINK Medical Board is pleased to announce the appointment of Anders... Read more
Scandion Oncology, an innovative drug efflux pump inhibition company using biomodulation capability to... Read more
ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) is... Read more
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th Copenhagen,... Read more
Financing led by TCGX, including new investment from TPG, Orbimed Advisors, Venrock Healthcare Capital... Read more
We are very excited to announce that Lasse Nørregaard has joined DANISH BIO’s board as an... Read more
Lophora, a clinical-stage CNS drug discovery company developing novel, next generation 5HT2ARA therapeutics... Read more
We’re partnering with TECHBBQ for a disount of 25%. TECHBBQ takes place in Copenhagen on 11-12... Read more
We are partnering with NLSDays 2024 for a good discount on the registration fees! NLSDays 2024 is in... Read more